Summary of Significant Accounting Policies (Tables)

12 Months Ended

Jun. 30, 2014

Summary of Significant Accounting Policies [Abstract]

Schedule of potential common stock

Warrants 4,012,500

Schedule of derivative liabilities, fair value

Warrant liability:	June 30, 2014		March 14, 2014		September 9, 2013
4,000,000 common stock purchase agreement dated September 9, 2013 *	$	-	$	1,482,326	$	1,243,455
3,750,000 common stock purchase agreement dated March 14, 2014		554,828		562,761		-
	$	554,828	$	2,045,087	$	1,243,455

*On March 14, 2014, the 3 subscribers, who were subscribers in an offering undertaken by the Company on September 9, 2013, along with 2 subscribers that did not elect to participate in this offering, executed a waiver and consent in regard to their rights under the September 9, 2013 offering (the “Original SPA”), whereby they waived the rights to receive any additional shares of common stock under the Original SPA agreements and the Company and the 5 investors agreed to a re-pricing of the warrants issued under the Original SPA from an exercise price of $0.30 per share to $0.0724 per share and that such reduction of the Exercise Price was deemed a reduction in connection with a Dilutive Issuance (as defined in the Warrants) and the number of Warrant Shares that may be purchased upon exercise of the Warrants increased.  On March 14, 2014 through March 21, 2014, the Company received notices and executed cashless exercise from the subscribers under the Original SPA.

Schedule in number of common shares derivative financial instruments

	Warrant Derivatives
4,000,000 common stock purchase agreement dated September 9, 2013		-
3,750,000 common stock purchase agreement dated March 14, 2014		4,012,500
		4,012,500

Schedule of changes in fair values of derivative financial instruments

	Fiscal Year ended
	June 30,
		2014			2013
4,000,000 common stock purchase agreement dated September 9, 2013	$	176,853		$	-
3,750,000 common stock purchase agreement dated March 14, 2014		(7,932	)		-
	$	168,921		$